LPS/d-GalN |
Acute liver injury |
Inhibits the activation of NF-κB and MAPK signaling pathways and inhibits the expression of apoptosis-related proteins induced by LPS/d-GalN |
Decreases the production of LPS/d-GalN induced by oxidation markers [33] |
Toosendanin |
Liver toxicity |
Induces Nrf2/GCL/GSH antioxidant signal transduction pathways |
Increases Nrf2-mediated GCLC/GCLM expression, thereby increasing GSH content in cells [34] |
Alcohol |
Liver damage |
Regulates phosphoinositide 3-kinase/Akt/NF-κB and STAT3 pathways |
Enhances the body’s antioxidant, anti-inflammatory, and anti-apoptotic effects [35] |
A variety of liver toxins |
Liver toxicity |
Induces p62 expression and inhibits the binding of Keap1 and Nrf2 |
Increases the transcription expression of Nrf2-targeted antioxidant genes [36] |
Doxorubicin |
Heart toxicity |
Upregulates Bmi-1 expression to reduce oxidative stress |
Reduces DNA damage at ROS levels and maintains cardiomyocyte viability [37] |
CCl4
|
Liver damage |
Improves antioxidant activity and regulates TLR2/TLR4 and MAPK/NF-κB signaling pathways |
Inhibits ROS production in the liver and attenuates CCl4-induced oxidative damage [38] |
Lead |
Liver damage |
Reduces oxidative stress in liver, inhibits JNK phosphorylation, and increases PI3K and Akt levels |
Effectively inhibits lead-induced endoplasmic reticulum stress [39] |
Cadmium |
Cerebral cholinergic dysfunction |
Reduces the production of ROS and protects the integrity of the line by regulating the protein involved in apoptosis and MAPK signal conduction |
Regulates molecular targets involved in the signal conduction of brain cholinergic energy and reduces the neurotoxicity of cadmium [40] |
Malignant cell transformation |
Protects BEAS-2B cells from Cr (VI) induction by targeting miR-21-PDCD4 signaling |
Reduces ROS production induced by Cr (VI) exposure in BEAS-2B cells [41] |
d-lactose |
Cognitive impairment and neuron degeneration or loss |
Improves the Nrf2-ARE signaling pathway |
Decreases free radicals, increases antioxidant enzyme activity, improves overall antioxidant capacity, and slows down aging by improving Nrf2 [42] |
Receptor activator for NF-κB ligand |
Osteoblast differentiation |
Regulates the transcription activities of NF-κB and AP-1 |
Inhibits the NF-κB and AP-1 mechanism activation [43] |